Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
about
Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosingDolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings.Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review.Dolutegravir-based anti-retroviral therapy is effective and safe in HIV-infected paediatric patients.Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy
P2860
Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Successful prevention of HIV m ...... s highly drug-resistant HIV-1.
@en
type
label
Successful prevention of HIV m ...... s highly drug-resistant HIV-1.
@en
prefLabel
Successful prevention of HIV m ...... s highly drug-resistant HIV-1.
@en
P50
P921
P1433
P1476
Successful prevention of HIV m ...... s highly drug-resistant HIV-1.
@en
P2093
Giovanni Scambia
Mauro Tintoni
P304
P356
10.1097/QAD.0000000000000888
P407
P50
P577
2015-09-13T00:00:00Z